F
Fang Fang
Researcher at Bayer HealthCare Pharmaceuticals
Publications - 1
Citations - 233
Fang Fang is an academic researcher from Bayer HealthCare Pharmaceuticals. The author has contributed to research in topics: Liver cancer & Hepatocellular carcinoma. The author has an hindex of 1, co-authored 1 publications receiving 208 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
Ann-Lii Cheng,Zhongzhen Guan,Zhendong Chen,Chao Jung Tsao,Shukui Qin,Jun Suk Kim,Tsai Sheng Yang,Won Young Tak,Hongming Pan,Shiying Yu,Jianming Xu,Fang Fang,Jessie Zou,Giuseppe Lentini,D. Voliotis,Yoon-Koo Kang +15 more
TL;DR: Experimental analyses suggest that sorafenib is effective for patients from the AP region with advanced HCC, irrespective of baseline status, and the efficacy and safety profiles in the subpopulations described were comparable with those in the overall study population.